Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.

In a case report published in the World Journal of Oncology, an elderly female patient was diagnosed with mast cell leukemia (MCL), with imaging showing extensive osteoblastic metastatic lesions. MCL ...

DUOncoTM Bone : First CE marked IA algorithm for automatic detection of bone lesions on CT scan. DUOncoTM Bone : First CE ...

Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands: Melbourne, Australia Wednesday, March 19, 2025, 12:00 Hrs [IST] Telix, a biopharmaceutical c ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Research accelerates innovation across industrial lines for cutting-edge semiconductor manufacturing, AI computing power, ...

Joe Lawton's life was changed forever when he was diagnosed with a rare form of cancer just two days before his 14th birthday ...

LEADOPTIK Inc., a Silicon Valley-based medical imaging company today announced that it has entered into a research collaboration with Stanford Medicine to explore the use of AI-enhanced real-time ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for cutting-edge treatment. The CAR T-cell therapy involves the col ...

While Drew had a breast reduction when she was 17 years old, she's been vocal that she would never get any plastic surgery ...

Learn more about whether Globus Medical, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor ...